Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Similar content being viewed by others Introduction The current worldwide epidemic of type 2 diabetes constitutes one of the major unmet challenges of public health
In the SURMOUNT-1 trial, 95 percent of participants taking tirzepatide reverted to normal blood sugar over 176 weeks, and 99 percent stayed diabetes-free
Within this high-oxidative-stress microenvironment, IL-17A suppresses the expression of GPX4, the core defense enzyme against ferroptosis, via the ACT1-TRAF6-p38 MAPK pathway
Shapira, Y., Harel, S
Hoppel C
Washington, DC: American Psychiatric Association
US$ 28.56
US$ 22.02
US$ 29.07
US$ 28.16
